Genetics

This blog post examines the study by Kreft et al. on the clinical relevance of multiple sclerosis severity-associated genetic variants in a real-world cohort. The article evaluates whether recently identified variants, particularly rs10191329A, can predict long-term disability, relapse patterns, EDSS milestones, and progression to secondary progressive MS. Although some suggestive variants showed modest associations with disability outcomes, the main severity genotype did not reliably predict disease course. The post highlights the importance of independent replication, careful clinical phenotyping, and the current limitations of using individual genetic markers for MS prognosis or treatment decisions.